Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event

Autor: Lorenz Balcar, Marta Tonon, Georg Semmler, Valeria Calvino, Lukas Hartl, Simone Incicco, Mathias Jachs, David Bauer, Benedikt Silvester Hofer, Carmine Gabriele Gambino, Antonio Accetta, Alessandra Brocca, Michael Trauner, Mattias Mandorfer, Salvatore Piano, Thomas Reiberger

Publikováno v: JHEP Reports. 4:100513

Although ascites is the most frequent first decompensating event in cirrhosis, the clinical course after ascites as theA total of 622 patients with cirrhosis presenting with grade 2/3 ascites as theThe mean age was 57 ± 11 years, and most patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf81a5f893918c40914501beaf552554
https://doi.org/10.1016/j.jhepr.2022.100513

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.

Autor: Balcar L; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Tonon M; Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padua, Italy., Semmler G; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Calvino V; Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padua, Italy., Hartl L; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Incicco S; Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padua, Italy., Jachs M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Bauer D; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Hofer BS; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Christian-Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria., Gambino CG; Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padua, Italy., Accetta A; Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padua, Italy., Brocca A; Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padua, Italy., Trauner M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Mandorfer M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Piano S; Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padua, Italy., Reiberger T; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Christian-Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria.

Publikováno v: JHEP reports : innovation in hepatology [JHEP Rep] 2022 Jun 03; Vol. 4 (8), pp. 100513. Date of Electronic Publication: 2022 Jun 03 (Print Publication: 2022).

Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.

Autor: Praktiknjo M; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., Abu-Omar J; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., Chang J; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., Thomas D; Department of Radiology, University Hospital Bonn, Bonn, Germany., Jansen C; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., Kupczyk P; Department of Radiology, University Hospital Bonn, Bonn, Germany., Schepis F; Division of Gastroenterology, Azienda Ospedaliero-Universitaria di Modena and University of Modena and Reggio Emilia, Modena, Italy., Garcia-Pagan JC; Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic, IDIBAPS and CIBERehd, Barcelona, Spain., Merli M; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Meyer C; Department of Radiology, University Hospital Bonn, Bonn, Germany., Strassburg CP; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., Pieper CC; Department of Radiology, University Hospital Bonn, Bonn, Germany., Trebicka J; Department of Internal Medicine I, University of Frankfurt, Frankfurt, Germany.; European Foundation for the Study of Chronic Liver Failure - EF CLIF, Barcelona, Spain.

Publikováno v: JHEP reports : innovation in hepatology [JHEP Rep] 2021 Mar 03; Vol. 3 (3), pp. 100264. Date of Electronic Publication: 2021 Mar 03 (Print Publication: 2021).